Philip T. Ninan

13.6k total citations · 3 hit papers
111 papers, 8.7k citations indexed

About

Philip T. Ninan is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Philip T. Ninan has authored 111 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pharmacology, 44 papers in Experimental and Cognitive Psychology and 34 papers in Psychiatry and Mental health. Recurrent topics in Philip T. Ninan's work include Treatment of Major Depression (51 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (36 papers) and Mental Health Research Topics (24 papers). Philip T. Ninan is often cited by papers focused on Treatment of Major Depression (51 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (36 papers) and Mental Health Research Topics (24 papers). Philip T. Ninan collaborates with scholars based in United States, Germany and Canada. Philip T. Ninan's co-authors include A. John Rush, Susan G. Kornstein, Michael E. Thase, Madhukar H. Trivedi, Martin B. Keller, Daniel N. Klein, James H. Kocsis, John C. Markowitz, Rachel Manber and Bruce A. Arnow and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Philip T. Ninan

102 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003 3.0k citations A. John Rush, Madhukar H. Trivedi et al. Biological Psychiatry profile →
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

2003 569 citations Charles B. Nemeroff, Michael E. Thase et al. profile →
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

2006 535 citations A. John Rush, Harold A. Sackeïm et al. profile →

Peers

Countries citing papers authored by Philip T. Ninan

Since Specialization

Citations

This map shows the geographic impact of Philip T. Ninan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip T. Ninan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip T. Ninan more than expected).

Fields of papers citing papers by Philip T. Ninan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip T. Ninan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip T. Ninan. The network helps show where Philip T. Ninan may publish in the future.

Co-authorship network of co-authors of Philip T. Ninan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip T. Ninan. A scholar is included among the top collaborators of Philip T. Ninan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip T. Ninan. Philip T. Ninan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study 2013 ·The Journal of Nervous and Mental Disease ·Alan J. Gelenberg, David L. Dünner, Anthony J. Rothschild, Ron Pedersen, Kathleen M. Dorries, Philip T. Ninan	14
2	Recovery and subsequent recurrence in patients with recurrent major depressive disorder 2012 ·Journal of Psychiatric Research ·Boadie W. Dunlop, Peter Holland, Weihang Bao, Philip T. Ninan, Martin B. Keller	13
3	Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients 2011 ·The Primary Care Companion For CNS Disorders ·Michael E. Thase, Philip T. Ninan, Jeff Musgnung, Madhukar H. Trivedi	11
4	Analysis of the Effect of Desvenlafaxine on Anxiety Symptoms Associated with Major Depressive Disorder: Pooled Data from 9 Short-Term, Double-blind, Placebo-Controlled Trials 2010 ·CNS Spectrums ·Karen A. Tourian, Qin Jiang, Philip T. Ninan	15
5	Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder 2010 ·Journal of Psychiatric Research ·Boadie W. Dunlop, Thomas Li, Susan G. Kornstein, Edward S. Friedman, Anthony J. Rothschild, Ron Pedersen, Philip T. Ninan, Martín Keller, Madhukar H. Trivedi	43
6	Desvenlafaxine and Weight Change in Major Depressive Disorder 2010 ·The Primary Care Companion to The Journal of Clinical Psychiatry ·Karen A. Tourian, (unknown), Jay Graepel, Philip T. Ninan	12
7	Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity 2009 ·European Archives of Psychiatry and Clinical Neuroscience ·Andreas Schmitt, Michael Bauer, Hans‐Peter Volz, (unknown), Qin Jiang, Philip T. Ninan, (unknown)	22
8	A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression 2008 ·Journal of Psychiatric Research ·Gabor I. Keitner, Steven J. Garlow, Christine E. Ryan, Philip T. Ninan, David A. Solomon, Charles B. Nemeroff, Martin B. Keller	75
9	Use of Dialectical Behavior Therapy in Borderline Personality Disorder: A View From Residency 2007 ·Academic Psychiatry ·Bhanu Sharma, Boadie W. Dunlop, Philip T. Ninan, Ronald H. Bradley	8
10	Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study 2007 ·The Journal of Clinical Psychiatry ·James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, Richard C. Shelton, Susan G. Kornstein, Charles B. Nemeroff, Edward S. Friedman, Alan J. Gelenberg, David L. Dünner, Robert M. A. Hirschfeld, Anthony J. Rothschild, James M. Ferguson, Alan F. Schatzberg, John Zajecka, Ronald Pedersen, Bing Chun Yan, Saeed Ahmed, Jeff Musgnung, Philip T. Ninan, Martín Keller	46
11	Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness 2007 ·Journal of Clinical Psychopharmacology ·Boadie W. Dunlop, Paul Crits‐Christoph, Dwight L. Evans, Jack Hirschowitz, H. Brent Solvason, Karl Rickels, Steven J. Garlow, Robert Gallop, Philip T. Ninan	41
12	Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study 2005 ·Biological Psychiatry ·A. John Rush, Harold A. Sackeïm, Lauren B. Marangell, Mark S. George, Stephen K. Brannan, Sonia M. Davis, Phil Lavori, Robert H. Howland, Mitchel A. Kling, Barry R. Rittberg, Linda L. Carpenter, Philip T. Ninan, Francisco Moreno, Sonia Thomas, Charles R. Conway, Michael J. Burke, John J. Barry	270
13	A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression 2005 ·Biological Psychiatry ·Mark S. George, A. John Rush, Lauren B. Marangell, Harold A. Sackeïm, Stephen K. Brannan, Sonia M. Davis, Robert H. Howland, Mitchel A. Kling, Francisco Moreno, Barry R. Rittberg, David L. Dünner, Sonia Thomas, Linda L. Carpenter, Michael J. Burke, Philip T. Ninan, Paul J. Goodnick	254
14	The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression breakdown → 2003 ·Biological Psychiatry ·A. John Rush, Madhukar H. Trivedi, (unknown), Thomas Carmody, Bruce A. Arnow, Daniel N. Klein, John C. Markowitz, Philip T. Ninan, Susan G. Kornstein, Rachel Manber, Michael E. Thase, James H. Kocsis, Martin B. Keller	2955
15	A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder 2003 ·The Journal of Clinical Psychiatry ·Eric Hollander, (unknown), Wayne K. Goodman, John H. Greist, Philip T. Ninan, Haichen Yang, David Li, Luigi Barbato	74
16	Introduction: Generalized Anxiety Disorder: Why Are We Failing Our Patients? 2001 ·The Journal of Clinical Psychiatry ·Philip T. Ninan	5
17	Symptomatic and syndromal anxiety and depression 2001 ·Depression and Anxiety ·Philip T. Ninan, Joseph R. Berger	35
18	Insight and treatment outcome in obsessive-compulsive disorder 2001 ·Comprehensive Psychiatry ·Jonathan A. Eisen, Steven A. Rasmussen, Katharine A. Phillips, Lawrence H. Price, Jonathan Davidson, R. Bruce Lydiard, Philip T. Ninan, (unknown)	120
19	Use of venlafaxine other psychiatric disorders 2000 ·Depression and Anxiety ·Philip T. Ninan	11
20	Venlafaxine: A novel antidepressant that has a dual mechanism of action 1996 ·PubMed ·James Andrews, Philip T. Ninan, Charles B. Nemeroff	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact